Roger W. Jelliffe, M.D. (1929–2020) Hartmut DerendorfCharles Peloquin EDITORIAL 13 August 2020 Pages: 1063 - 1063
Pharmacokinetics and Generic Drug Switching: A Regulator’s View Pieter J. GlerumCees NeefMarc Maliepaard Current Opinion Open access 17 June 2020 Pages: 1065 - 1069
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review Anselm JordaMarkus Zeitlinger Review Article Open access 30 April 2020 Pages: 1071 - 1084
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review Anthony T. PodanyKimberly K. ScarsiCourtney V. Fletcher Review Article 27 May 2020 Pages: 1085 - 1107
Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects Cara H. NelsonKim EtcheversAnita Mathias Original Research Article 25 April 2020 Pages: 1109 - 1117
Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies Lukas KovarDominik SelzerThorsten Lehr Original Research Article Open access 12 March 2020 Pages: 1119 - 1134
Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer Ignacio DuranJoan CarlesCaly Chien Original Research Article 27 April 2020 Pages: 1135 - 1148
Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model An Van den BerghJan SnoeysCaly Chien Original Research Article 27 April 2020 Pages: 1149 - 1160
An Extension of Janmahasatian’s Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities Jaydeep SinhaHesham S. Al-SallamiStephen B. Duffull Original Research Article 22 March 2020 Pages: 1161 - 1170
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies Fanny GallaisLoïc YsebaertMélanie White-Koning Original Research Article 24 April 2020 Pages: 1171 - 1183